Department of Pathobiology, Institute of Parasitology, University of Veterinary Medicine Vienna, Vienna, Austria.
Department for Farm Animals and Veterinary Public Health, University Clinic for Ruminants, University of Veterinary Medicine Vienna, Vienna, Austria.
Parasit Vectors. 2024 Jul 9;17(1):296. doi: 10.1186/s13071-024-06377-4.
The population of South American camelids (SAC) has been steadily growing in Europe, where they are confronted with the regional endoparasite population of ruminants. As there are no anthelmintic drugs registered for use against nematode infections in SACs, anthelmintics (AH) available for ruminants or horses are usually applied. Reports indicating potential failures in administered AH are increasing. However, the generally low egg counts in SACs complicate the application of resistance tests in the field. The present study reports a follow-up study on SAC farms where anthelmintic resistance (AR) was suspected. The aims were (i) to repeat faecal egg count reduction tests (FECRTs) on potentially affected farms identified in a previous study with larger sample sizes, (ii) to verify suspected AR of Haemonchus contortus against benzimidazoles (BZ) by performing a single-nucleotide polymorphism (SNP) analysis using digital polymerase chain reaction (dPCR), and (iii) to apply the mini-FLOTAC technique for more reliable results at low egg counts in line with current recommendations. Seven farms (9-46 animals each) were examined by coproscopy, larval differentiation and SNP analysis. A FECRT was performed on six of these farms with moxidectin (three farms), monepantel (two farms) and ivermectin (one farm). The FEC was calculated according to the current World Association for the Advancement of Veterinary Parasitology (WAAVP) guidelines with the clinical protocol (a newly introduced variant of FECRT which can be used for smaller sample sizes and lower egg counts on the cost of sensitivity) and an expected efficacy of 99%. A high level (> 90%) of BZ-resistance-associated SNPs on codon 200 of H. contortus was observed on all farms. With the FECRT, resistance was demonstrated for ivermectin (74% FECR), while it remained inconclusive for one farm for moxidectin treatment. Sustained efficacy was demonstrated for the remaining treatments. This study showed an advanced level of BZ resistance in H. contortus of SACs and the development of AR against macrocyclic lactones on some farms. Thus, constant monitoring of AH treatment and sustainable worm control methods both need to be applied.
南美栗色羊驼(SAC)的数量在欧洲稳步增长,而在那里,它们面临着当地反刍动物的内寄生虫种群。由于没有针对 SAC 线虫感染的驱虫药物注册,因此通常会使用适用于反刍动物或马的驱虫药物(AH)。表明 AH 给药失败的报告越来越多。然而,SAC 中通常较低的虫卵计数使现场抗药性测试的应用变得复杂。本研究报告了对疑似存在驱虫药物抗药性(AR)的 SAC 农场的后续研究。目的是(i)在前一项研究中,使用更大的样本量重复对先前鉴定出的潜在受影响农场进行粪便虫卵减少试验(FECRT),(ii)通过使用数字聚合酶链反应(dPCR)进行单核苷酸多态性(SNP)分析,以验证对苯并咪唑类药物(BZ)有怀疑的抗 Haemonchus contortus 抗药性,(iii)根据当前的建议,应用 mini-FLOTAC 技术在低虫卵计数下获得更可靠的结果。通过粪便检查、幼虫分化和 SNP 分析对七个农场(每个农场 9-46 只动物)进行了检查。对其中六个农场使用莫昔克丁(三个农场)、莫能菌素(两个农场)和伊维菌素(一个农场)进行了 FECRT。根据当前世界兽医寄生虫学会(WAAVP)的指导原则,根据临床方案(一种新引入的 FECRT 变体,可用于较小的样本量和较低的虫卵计数,但其敏感性降低)计算 FEC,预计疗效为 99%。在所有农场中均观察到 Haemonchus contortus 密码子 200 处与 BZ 耐药相关的 SNP 水平较高(>90%)。通过 FECRT,伊维菌素(74%的 FECR)表现出耐药性,而莫昔克丁治疗的一个农场的结果仍不确定。其余治疗方法均显示出持续的疗效。本研究表明,SAC 的 Haemonchus contortus 中存在高水平的 BZ 耐药性,并且一些农场对大环内酯类药物产生了抗药性。因此,需要持续监测 AH 治疗和可持续的驱虫控制方法。